Cargando…

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors

The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors is intended to assist medical professionals who evaluate living kidney donor candidates and provide care before, during and after donation. The guideline developm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lentine, Krista L., Kasiske, Bertram L., Levey, Andrew S., Adams, Patricia L., Alberú, Josefina, Bakr, Mohamed A., Gallon, Lorenzo, Garvey, Catherine A., Guleria, Sandeep, Li, Philip Kam-Tao, Segev, Dorry L., Taler, Sandra J., Tanabe, Kazunari, Wright, Linda, Zeier, Martin G., Cheung, Michael, Garg, Amit X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540357/ https://www.ncbi.nlm.nih.gov/pubmed/28742762 http://dx.doi.org/10.1097/TP.0000000000001769

Ejemplares similares

Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
por: Lentine, Krista L., et al.
Publicado: (2017)

Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
por: Chadban, Steven J., et al.
Publicado: (2020)

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation
por: Lentine, Krista L., et al.
Publicado: (2019)

Diabetic Kidney Disease– A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
por: Molitch, Mark E., et al.
Publicado: (2014)

Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis
por: Nazzal, Mustafa, et al.
Publicado: (2018)

KDIGO-Leitlinie zu Evaluation und Management von Nierentransplantationskandidaten: Kommentierte deutsche Übersetzung der Zusammenfassung
por: Morath, Christian, et al.
Publicado: (2022)

Outcomes of Living Kidney Donor Candidate Evaluations in the Living Donor Collective Pilot Registry
por: Kasiske, Bertram L., et al.
Publicado: (2021)

Correction to: High-dose opioid utilization and mortality among individuals initiating hemodialysis
por: Daubresse, Matthew, et al.
Publicado: (2021)

High-dose opioid utilization and mortality among individuals initiating hemodialysis
por: Daubresse, Matthew, et al.
Publicado: (2021)

KDIGO Board Members
Publicado: (2012)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
por: Axelrod, David A., et al.
Publicado: (2020)

End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?
por: Lam, Ngan N., et al.
Publicado: (2014)

Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Nomenclature for kidney function and disease—executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
por: Levey, Andrew S, et al.
Publicado: (2020)

Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
por: Levey, Andrew S., et al.
Publicado: (2020)

Recovery from AKI by KDIGO criteria
por: Schrijvers, D, et al.
Publicado: (2014)

Policy Strategies to Reduce Financial Risks for Living Donors
por: Husain, Syed Ali, et al.
Publicado: (2023)

Evaluating the feasibility of the KDIGO CKD referral recommendations
por: Singh, Karandeep, et al.
Publicado: (2017)

Abstract 28: Trends in Industry Payments to Plastic Surgeons - What does the Sunshine Act Database Tell Us?
por: Ahmed, Rizwan, et al.
Publicado: (2019)

Abstract P23. Walking on Sunshine: Continued surveillance of Industry’s Payments to Plastic Surgeons
por: Ahmed, Rizwan, et al.
Publicado: (2017)

The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study
por: Eno, Ann K, et al.
Publicado: (2018)

From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
por: Stai, Stamatia, et al.
Publicado: (2022)

Deceased Donor Procurement Biopsy Practices, Interpretation, and Histology-Based Decision-Making: A Survey of US Kidney Transplant Centers
por: Lentine, Krista L., et al.
Publicado: (2022)

SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
por: Werbel, William A., et al.
Publicado: (2022)

Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications
por: Kuppachi, Sarat, et al.
Publicado: (2022)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

Incorrect application of the KDIGO acute kidney injury staging criteria
por: Yasrebi-de Kom, Izak A R, et al.
Publicado: (2021)

Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era
por: Lentine, Krista L., et al.
Publicado: (2020)

Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD
por: Mann, Johannes F. E., et al.
Publicado: (2021)

Has the quality of serosurveillance in low- and middle-income countries improved since the last HIV estimates round in 2007? Status and trends through 2009
por: Garcia Calleja, Jesus M, et al.
Publicado: (2010)

Follow-up Care of Living Kidney Donors in Alberta, Canada
por: Lam, Ngan N., et al.
Publicado: (2018)

Impact of Functional Status on Outcomes of Simultaneous Pancreas-kidney Transplantation: Risks and Opportunities for Patient Benefit
por: Lentine, Krista L., et al.
Publicado: (2020)

Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients
por: Axelrod, David A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qv7l50lm6pmbvodch8vunr58ia